Trials / Completed
CompletedNCT01660802
Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 262 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the safety and efficacy of 700 μg dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in patients with macular edema in a 6 month double-blind period versus sham followed by a 2 month open label period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 700 μg Dexamethasone | 700 μg Dexamethasone intravitreal injection in the study eye on Day 1. |
| OTHER | Sham | Sham administered in the study eye on Day 1. |
Timeline
- Start date
- 2012-09-04
- Primary completion
- 2014-03-31
- Completion
- 2014-05-20
- First posted
- 2012-08-09
- Last updated
- 2019-04-17
- Results posted
- 2015-06-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01660802. Inclusion in this directory is not an endorsement.